Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CEFTRIAXONE Cause Intensive care unit acquired weakness? 13 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Intensive care unit acquired weakness have been filed in association with CEFTRIAXONE (Ceftriaxone). This represents 0.1% of all adverse event reports for CEFTRIAXONE.

13
Reports of Intensive care unit acquired weakness with CEFTRIAXONE
0.1%
of all CEFTRIAXONE reports
0
Deaths
12
Hospitalizations

How Dangerous Is Intensive care unit acquired weakness From CEFTRIAXONE?

Of the 13 reports, 12 (92.3%) required hospitalization.

Is Intensive care unit acquired weakness Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CEFTRIAXONE. However, 13 reports have been filed with the FAERS database.

What Other Side Effects Does CEFTRIAXONE Cause?

Off label use (2,201) Drug ineffective (1,862) Condition aggravated (950) Dyspnoea (944) Pyrexia (843) Drug reaction with eosinophilia and systemic symptoms (793) Rash (784) Drug hypersensitivity (760) Acute kidney injury (720) Vomiting (668)

What Other Drugs Cause Intensive care unit acquired weakness?

METHYLPREDNISOLONE (57) PROPOFOL (55) MIDAZOLAM (49) PREDNISOLONE (47) PREDNISONE (45) MYCOPHENOLATE MOFETIL (42) THIOPENTAL (41) FENTANYL (40) LEVETIRACETAM (40) VANCOMYCIN (37)

Which CEFTRIAXONE Alternatives Have Lower Intensive care unit acquired weakness Risk?

CEFTRIAXONE vs CEFTRIAXONE\CEFTRIAXONE CEFTRIAXONE vs CEFUROXIME CEFTRIAXONE vs CEFUROXIME AXETIL CEFTRIAXONE vs CELEBREX CEFTRIAXONE vs CELECOXIB

Related Pages

CEFTRIAXONE Full Profile All Intensive care unit acquired weakness Reports All Drugs Causing Intensive care unit acquired weakness CEFTRIAXONE Demographics